Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Vilaprisan 2 mg A1 (3/1 Regimen)	363
Overall Study	STARTED	Vilaprisan 2 mg A2 (6/2 Regimen)	361
Overall Study	STARTED	Vilaprisan 2 mg A3 (3/2 Regimen)	183
Overall Study	STARTED	B (Standard of Care)	365
Overall Study	Treated	Vilaprisan 2 mg A1 (3/1 Regimen)	349
Overall Study	Treated	Vilaprisan 2 mg A2 (6/2 Regimen)	347
Overall Study	Treated	Vilaprisan 2 mg A3 (3/2 Regimen)	177
Overall Study	Treated	B (Standard of Care)	365
Overall Study	COMPLETED	Vilaprisan 2 mg A1 (3/1 Regimen)	59
Overall Study	COMPLETED	Vilaprisan 2 mg A2 (6/2 Regimen)	93
Overall Study	COMPLETED	Vilaprisan 2 mg A3 (3/2 Regimen)	44
Overall Study	COMPLETED	B (Standard of Care)	85
Overall Study	NOT COMPLETED	Vilaprisan 2 mg A1 (3/1 Regimen)	304
Overall Study	NOT COMPLETED	Vilaprisan 2 mg A2 (6/2 Regimen)	268
Overall Study	NOT COMPLETED	Vilaprisan 2 mg A3 (3/2 Regimen)	139
Overall Study	NOT COMPLETED	B (Standard of Care)	280

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03194646/flow